JPRN-jRCT1041200075
Recruiting
Phase 2
Randomized phase II study of preceding radiofrequency ablation to atezolizuma plus bevacizumab combination therapy for the patients with unresectable hepatocellular carcinoma
Yamashita Tatsuya0 sites66 target enrollmentDecember 15, 2020
Conditionshepatocellular carcinoma
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- hepatocellular carcinoma
- Sponsor
- Yamashita Tatsuya
- Enrollment
- 66
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •clinically diagnosed as hepatocellular carcinoma; unsuitable for local therapy; previously treated by systemic therapy; Preserved liver function; 20 years or older; ECOG Performance status \<\=2; preservation of major organ function; written informed consent
Exclusion Criteria
- •refractory ascites or pleural effusion; unsuitable for RFA, risky varices; double cancer; metastases to central nervous system; severe complication; pregnant or lactating women, or women of childbearing potential; mental disorder; patients who investigator regards as inappropriate for candidate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Study of Chlorophllin for reducing chemotherapy and radiotherapy treatment side effects in head and neck cancersHealth Condition 1: C139- Malignant neoplasm of hypopharynx,unspecifiedHealth Condition 2: C119- Malignant neoplasm of nasopharynx,unspecifiedHealth Condition 3: C109- Malignant neoplasm of oropharynx,unspecifiedHealth Condition 4: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynxCTRI/2023/07/055047Tata Memorial Hospital
Recruiting
Phase 2
A phase II study of consolidative radiotherapy for residual lesions during osimertinib monotherapy (ORIHALCON trial/WJOG13920L)JPRN-jRCTs041220115Kenmotsu Hirotsugu76
Active, not recruiting
Not Applicable
?Estudio Clínico en Fase II aleatorizado de radioterapia, hormonoterapia y quimioterapia con docetaxel versus radioterapia y hormonoterapia, en pacientes afectados de cáncer de próstata localizado de alto riesgo (Estadio III Y IV)?PACIENTES AFECTADOS DE CÁNCER DE PRÓSTATA LOCALIZADO DE ALTO RIESGO (ESTADIO III Y IV)EUCTR2008-003554-14-ESGrupo Español de Tratamiento de Tumores Urológicos (SOGUG)
Not yet recruiting
Not Applicable
A comparative study of surgeries done for treatment of varicosities in patients of varicose vein patients.CTRI/2020/03/024298Department of General Surgery
Active, not recruiting
Phase 1
A randomised Phase II/III trial to study radiotherapy dose escalation in patients with oesophageal cancer treated with definitive chemo-radiation with an embedded Phase II trial for patients with a poor early response using positron emission tomography (PET)on operable oesophageal cancer patientsMedDRA version: 19.1Level: LLTClassification code 10030151Term: Oesophageal cancerSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2015-001740-11-GBVelindre NHS Trust